These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38944874)
1. Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center. Hofstetter P; Zuber-Jerger I; Mehrl A; Graf B; Lunz D; Lubnow M; Müller T; Schmid S; Müller M; Kandulski A J Gastrointestin Liver Dis; 2024 Jun; 33(2):218-225. PubMed ID: 38944874 [TBL] [Abstract][Full Text] [Related]
2. Effect of endoscopic treatment in patients with secondary sclerosing cholangitis. Zhang CC; Sauer P; Rupp C J Gastroenterol Hepatol; 2022 Oct; 37(10):2011-2018. PubMed ID: 35933581 [TBL] [Abstract][Full Text] [Related]
3. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases. Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347 [TBL] [Abstract][Full Text] [Related]
4. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer. Linder S; Söderlund C Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315 [TBL] [Abstract][Full Text] [Related]
5. Endoscopic management of post-liver transplant billiary complications: A prospective study from tertiary centre in India. Ranjan P; Bansal RK; Mehta N; Lalwani S; Kumaran V; Sachdeva MK; Kumar M; Nundy S Indian J Gastroenterol; 2016 Jan; 35(1):48-54. PubMed ID: 26873087 [TBL] [Abstract][Full Text] [Related]
6. COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients. Ferreira FB; Mourato M; Bragança S; Paulo JB; Sismeiro R; Pereira A; Mónica AN; Lourenço LC; Cardoso M Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102048. PubMed ID: 36347499 [TBL] [Abstract][Full Text] [Related]
8. COVID-19-associated secondary sclerosing cholangitis with liver transplantation. Fischer AK; Stippel D; Canbay A; Nierhoff D; Thomas M; Best J; Büttner R; Drebber U Virchows Arch; 2024 Aug; 485(2):371-377. PubMed ID: 38526652 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of sclerosing cholangitis in children: blinded, comparative study of magnetic resonance versus endoscopic cholangiography. Rossi G; Sciveres M; Maruzzelli L; Curcio G; Riva S; Traina M; Tuzzolino F; Luca A; Gridelli B; Maggiore G Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):596-601. PubMed ID: 23830985 [TBL] [Abstract][Full Text] [Related]
10. Poor outcome in progressive sclerosing cholangitis after septic shock. Kulaksiz H; Heuberger D; Engler S; Stiehl A Endoscopy; 2008 Mar; 40(3):214-8. PubMed ID: 18264887 [TBL] [Abstract][Full Text] [Related]
11. Corona again? SSC after a severe COVID-disease. Arnstadt B; Zillinger C; Treitl M; Allescher HD Z Gastroenterol; 2021 Dec; 59(12):1304-1308. PubMed ID: 34666402 [TBL] [Abstract][Full Text] [Related]
12. Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report. Steiner J; Kaufmann-Bühler AK; Fuchsjäger M; Schemmer P; Talakić E World J Gastrointest Surg; 2022 Dec; 14(12):1411-1417. PubMed ID: 36632122 [TBL] [Abstract][Full Text] [Related]
13. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. Olsson R; Björnsson E; Bäckman L; Friman S; Höckerstedt K; Kaijser B; Olausson M J Hepatol; 1998 Mar; 28(3):426-32. PubMed ID: 9551680 [TBL] [Abstract][Full Text] [Related]
14. Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis. Vitellas KM; Enns RA; Keogan MT; Freed KS; Spritzer CE; Baillie J; Nelson RC AJR Am J Roentgenol; 2002 Feb; 178(2):327-34. PubMed ID: 11804887 [TBL] [Abstract][Full Text] [Related]
15. Detection of large intrahepatic cholangiectases in patients with primary sclerosing cholangitis by endoscopic retrograde cholangiography. Theilmann L; Stiehl A Endoscopy; 1990 Jan; 22(1):49-50. PubMed ID: 2307131 [TBL] [Abstract][Full Text] [Related]
16. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314 [TBL] [Abstract][Full Text] [Related]
17. Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis. Cazzagon N; Chazouillères O; Corpechot C; El Mouhadi S; Chambenois E; Desaint B; Chaput U; Lemoinne S; Arrivé L Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):387-394. PubMed ID: 30772328 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19. Tampe D; Korsten P; Bremer SCB; Winkler MS; Tampe B Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944657 [TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis. Rupp C; Bode KA; Chahoud F; Wannhoff A; Friedrich K; Weiss KH; Sauer P; Stremmel W; Gotthardt DN BMC Infect Dis; 2014 Oct; 14():562. PubMed ID: 25338733 [TBL] [Abstract][Full Text] [Related]